Point72 Asia (Singapore)’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$12.1K Buy
+1,000
New +$13.5K ﹤0.01% 765
2025
Q1
Sell
-899
Closed -$32.4K 1199
2024
Q4
$32.4K Sell
899
-1,569
-64% -$53.1K 0.01% 589
2024
Q3
$105K Buy
+2,468
New +$105K 0.02% 531
2024
Q2
Sell
-435
Closed -$15.4K 1486
2024
Q1
$15.4K Buy
+435
New +$11.7K ﹤0.01% 983

Other funds holding TNDM

Point72 Asia (Singapore)'s TNDM Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Tandem Diabetes Care (TNDM) in Q3 2025: 1,000 shares worth $12.1K. The stake represents ﹤0.01% of the portfolio and ranks #765 among its holdings. This is a return to the name: Point72 Asia (Singapore) previously reported a position in TNDM as recently as Q4 2024.

Point72 Asia (Singapore) first reported a position in TNDM in Q1 2024 and has held it in 4 quarters since. The position peaked at $105K in Q3 2024. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Point72 Asia (Singapore) held 1,000 shares of Tandem Diabetes Care worth $12.1K as of Q3 2025.
  • Tandem Diabetes Care was a new Point72 Asia (Singapore) position in Q3 2025.
  • Tandem Diabetes Care made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #765 holding.
  • Point72 Asia (Singapore) first reported a position in Tandem Diabetes Care in Q1 2024 and has held it in 4 quarters since.
  • Point72 Asia (Singapore)'s Tandem Diabetes Care position peaked at $105K in Q3 2024.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.